Pharmacovigilance: A Worldwide Master Key for Drug Safety Monitoring: Some Additional Information
2011
Pharmacovigilance in Vaccines
Commentary
Author Information
Author(s): Chetna Patel
Primary Institution: Government Medical College, Majuragate, Surat, India
Conclusion
The safety of vaccines must be prioritized more than other pharmacological agents to ensure public acceptance.
Supporting Evidence
- Vaccines are complex biological products that can cause adverse reactions.
- Evaluating vaccines is different from drugs due to unique immunological considerations.
- There is a significant communication gap in the current vaccine reporting system.
Takeaway
Vaccines can sometimes cause problems, so we need to be extra careful when giving them to people, especially kids.
Limitations
The current pharmacovigilance system for vaccines has communication gaps and challenges in assessing causality.
Participant Demographics
Vulnerable populations, including children, and healthy individuals.
Want to read the original?
Access the complete publication on the publisher's website